Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY

Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature. The aim of the study is to describe the frequency and nature of arterial and venous thromboembolic events and atrial fibrillation in patients with von Willebrand disease in the West of France. The investigators will perform a retrospective multicenter study conducted in the von Willebrand population of the French West. Von Willebrand adult patients followed in one of the French West medical centers participating in the study, who presented deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, atrial fibrillation, arteriopathy of the lower limbs, angina will be eligible.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Von Willebrand disease

• Adult

• Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers)

• Consented to be included in BERHLINGO database

• Have presented a thrombotic and/or embolic event or cardiovascular disease including deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia or angina or obliterating arteriopathy of the lower limbs, atrial fibrillation.

• Have not expressed their opposition

Locations
Other Locations
France
CHU d'Angers
NOT_YET_RECRUITING
Angers
CHU de Brest
RECRUITING
Brest
CHU de Caen
NOT_YET_RECRUITING
Caen
CH le MANS
NOT_YET_RECRUITING
Le Mans
CHU de Nantes
NOT_YET_RECRUITING
Nantes
CHU de Rennes
NOT_YET_RECRUITING
Rennes
Contact Information
Primary
Brigitte PAN PETESCH
brigitte.pan-petesch@chu-brest.fr
02.98.22.36.50
Backup
Sara ROBIN
sara.robin@chu-brest.fr
Time Frame
Start Date: 2021-12-26
Estimated Completion Date: 2026-12-26
Participants
Target number of participants: 100
Sponsors
Leads: University Hospital, Brest

This content was sourced from clinicaltrials.gov